Similar Papers

Paper Title
Journal
Date
Author
Commentary to ‘Outcome After 7 Years of Carotid Artery Stenting and Endarterectomy in Sweden – Single Centre and National Results’
G.J De Borst ... F.L Moll
European Journal of Vascular and Endovascular Surgery | VOL. 43
G.J De Borst, et. al.G.J De Borst ... F.L Moll
08 Mar 2012
Outcome After 7 Years of Carotid Artery Stenting and Endarterectomy in Sweden – Single Centre and National Results
D Lindström ... P Gillgren
Journal of Vascular Surgery | VOL. 55
D Lindström, et. al.D Lindström ... P Gillgren
27 Apr 2012
Outcome After 7 Years of Carotid Artery Stenting and Endarterectomy in Sweden – Single Centre and National Results
D Lindström ... P Gillgren
European Journal of Vascular and Endovascular Surgery | VOL. 43
D Lindström, et. al.D Lindström ... P Gillgren
18 Feb 2012
Phase II Clinical Trial to Evaluate the Efficacy and Safety of Activated T-Lymphocyte Cell Therapy in Gemcitabine Refractory Advanced Pancreatic Cancer
Moon Jae Chung ... Si Young Song
Gastroenterology | VOL. 140
Moon Jae Chung, et. al.Moon Jae Chung ... Si Young Song
21 Apr 2011
View more papers

More From: Transplant International

Paper Title
Journal
Date
Author
Mono-HOPE Versus Dual-HOPE in Liver Transplantation: A Propensity Score-Matched Evaluation of Early Graft Outcome
Dominik Thomas Koch ... Dionysios Koliogiannis
Transplant International | VOL. 38
Dominik Thomas Koch, et. al.Dominik Thomas Koch ... Dionysios Koliogiannis
05 Feb 2025
Role of a Porcine Herpesvirus, PCMV/PRV, in Xenotransplantation
Joachim Denner
Transplant International | VOL. 38
Joachim DennerJoachim Denner
04 Feb 2025
Innovations in Lung Transplant Research and Practice: The Future is Now
Robin Vos ... Norihisa Shigemura
Transplant International | VOL. 38
Robin Vos, et. al.Robin Vos ... Norihisa Shigemura
04 Feb 2025
Transplant Trial Watch
John M O’Callaghan ... Simon R Knight
Transplant International | VOL. -
John M O’Callaghan, et. al.John M O’Callaghan ... Simon R Knight
30 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.